News
SBMFF
0.651
NaN%
--
Weekly Report: what happened at SBMFF last week (0810-0814)?
Weekly Report · 1d ago
Daiwa Remains a Buy on Sino Biopharmaceutical (SBMFF)
TipRanks · 4d ago
Weekly Report: what happened at SBMFF last week (0803-0807)?
Weekly Report · 08/10 10:02
Sino Biopharm Wins NMPA Approval for New First-Line Lung Cancer Regimen
TipRanks · 08/07 11:47
Sino Biopharm Wins Approval for Next-Generation Flurbiprofen Pain Patch
TipRanks · 08/06 09:43
Sino Biopharm Wins China CDE Acceptance for Novel Leukemia Drug TQB3909
TipRanks · 08/04 09:10
Weekly Report: what happened at SBMFF last week (0727-0731)?
Weekly Report · 08/03 10:01
Sino Biopharm’s HER2 bispecific ADC TQB2102 gains third breakthrough tag in China
TipRanks · 08/03 08:42
Sino Biopharmaceutical to Showcase 21 Oncology Studies at 2026 CSCO Meeting
TipRanks · 07/30 08:40
Nomura Sticks to Its Buy Rating for Sino Biopharmaceutical (SBMFF)
TipRanks · 07/28 00:27
Sino Biopharmaceutical (SBMFF) Receives a Buy from UBS
TipRanks · 07/28 00:26
Weekly Report: what happened at SBMFF last week (0720-0724)?
Weekly Report · 07/27 10:05
Sino Biopharmaceutical Forms Indonesia Joint Venture With Tempo Scan
TipRanks · 07/27 09:11
Sino Biopharmaceutical (SBMFF) Receives a Buy from UOB Kay Hian
TipRanks · 07/25 14:55
Sino Biopharm Wins NMPA Nod for Innovative Hepatitis B Drug Trial
TipRanks · 07/23 10:09
Citi Sticks to Its Buy Rating for Sino Biopharmaceutical (SBMFF)
TipRanks · 07/23 00:26
Weekly Report: what happened at SBMFF last week (0713-0717)?
Weekly Report · 07/20 10:02
Sino Biopharmaceutical Wins Breakthrough Status for AI-Designed Neuropathic Pain Drug TRD205
TipRanks · 07/14 10:37
HSBC Sticks to Its Buy Rating for Sino Biopharmaceutical (SBMFF)
TipRanks · 07/14 00:26
Analysts Are Bullish on Top Healthcare Stocks: Praxis Precision Medicines (PRAX), Sino Biopharmaceutical (SBMFF)
TipRanks · 07/13 12:40
More
Webull provides a variety of real-time SBMFF stock news. You can receive the latest news about Sino Biopharmaceutical Limited through multiple platforms. This information may help you make smarter investment decisions.
About SBMFF
Sino Biopharmaceutical Ltd is an investment holding company mainly engaged in the pharmaceutical business. The Company operates its business through three segments. The Modernised Chinese Medicines and Chemical Medicines segment is mainly engaged in the manufacture, sale and distribution of modernised Chinese medicine products and western medicine products. The Investment segment is mainly engaged in the long term investments business. The Others segment is mainly engaged in the related healthcare and hospital business.